Herpes zoster reactivation in a cohort of people living with HIV vaccinated with recombinant vaccine
This is the first real-world study that highlights the excellent clinical response to RZV, with a low prevalence of HZ reactivation and complete resolution of PHN after the vaccination. Moreover, we identified clinical conditions promoting the recurrence HZ after vaccination.
Authors
- Davide Laurenda
- Stefania Arsuffi
- Ilaria Izzo (ORCID: https://orcid.org/0000-0001-9611-6160)
- Luca Rossi (ORCID: https://orcid.org/0000-0002-2110-9502)
- Stefano Calza (ORCID: https://orcid.org/0000-0003-4996-7995)
- Deborah Castelli
- Emanuele Focà (ORCID: https://orcid.org/0000-0003-4395-5379)
- Francesco Castelli (ORCID: https://orcid.org/0000-0001-9161-7804)
- Itala Polesini
- Stefano Rapino
- Miriam Inverardi
- Francesca Gaffurini
- Francesca Colombo (ORCID: https://orcid.org/0000-0002-8099-0192)
- Eugenia Quiros-Roldan
- Elisa Mirovic
Institutions
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- University of Brescia (IT)
Publication Details
- Journal
- Vaccine
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1016/j.vaccine.2025.127723
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00